TIS - EMA position may be reasonable, page-3

amc, your guess is as good as any. It makes sense to me that the EMA would want this same data upfront as the FDA. The blast from the past (the trial announcement) shows with hindsight just how overly optimistic management have been through the whole process. Instead of 2nd quarter 2012 sales it seems that the earliest we can look forward to sales is over three years past that particular estimate.

I am hoping that their confidence in the quality and stability of the product is not similarly misplaced.
I am taking some heart from the trading today. It wasn't as bad as I thought it might be. I wonder if we will see a few notifications about increases to substantial holdings over the short term?